This inventor holds 1 USPTO granted patent. Top assignee: The Schepens Eye Research Institute, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: **Timothy L. Kessler: Innovator in Ocular Therapeutics**
Introduction
Timothy L. Kessler is a prominent inventor based in Boston, MA. He has made significant contributions to the field of ocular medicine through his innovative approaches to treating eye disorders. His groundbreaking work focuses on the treatment of abnormal conjunctival goblet cell mucous secretion, providing promising solutions for patients suffering from related eye conditions.
Latest Patents
Kessler holds a patent for a method titled "Therapeutic regulation of abnormal conjunctival goblet cell mucous." This invention outlines a method for treating patients with aberrant conjunctival goblet cell mucous secretion linked to eye disorders or injuries. The method is based on the understanding that goblet cell mucous secretion is regulated by the autonomic nervous system. It involves administering a neural system stimulus or inhibitor targeting functions of the sensory, parasympathetic, or sympathetic nervous system to the affected eye. The patent also includes a therapeutic composition and an article of manufacture leveraging this innovative method.
Career Highlights
Timothy L. Kessler is affiliated with the Schepens Eye Research Institute, Inc., an esteemed research institution dedicated to advancing the understanding and treatment of eye diseases. His work reflects a commitment to improving patient outcomes through innovative research and development in ocular therapeutics.
Collaborations
Kessler collaborates closely with Darlene A. Dartt, a fellow researcher in the field. Their joint efforts in ocular research have the potential to yield significant advancements in treatments for various eye conditions, showcasing the power of teamwork in scientific innovation.
Conclusion
Timothy L. Kessler's contributions to the field of ocular medicine through his patent and ongoing research signify a substantial advancement in treating eye disorders. His innovative method for regulating abnormal conjunctival goblet cell mucous suggests a promising future for patients affected by these conditions, highlighting the critical role inventors play in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
